Tech Company Financing Transactions

Turnstone Biologics Funding Round

Turnstone Biologics closed a $80 million Series D funding round on 7/22/2021. Backers included Partner Fund Management, Point72 Ventures and 404 Bio.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

12 York St. 3rd Floor
Ottawa Ontario, K1N 5S6
Canada

Phone

(613) 421-8930

Website

www.turnstonebio.com

Email Address

[email protected]

Overview

Turnstone Biologics Inc. is a biotechnology company focused on developing novel oncolytic viral immunotherapies for cancer.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sammy Farah

        

Chief Financial Officer

Jane Henderson

        

Vice President

Caroline Breitbach

        

VP - Human Resources

Kristin Gustafson

        

VP - Operations

José Otero

        

VP - R & D

Michael Burgess

        

VP - R & D

Brian Lichty

        

Browse more venture capital transactions:

Prev: 7/22/2021: Carbon Health venture capital transaction
Next: 7/22/2021: Turquoise Health venture capital transaction

Share this article

News on VC Transactions

We do our best to document every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary